McGeorge Anne bought DNTH
August 10, 2026 · Form 4 insider transaction
McGeorge Anne bought 1,250 shares of Dianthus Therapeutics, Inc. at $19.36 per share, a transaction worth $24.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,250
Price
$19.36
Total value
$24.2K
InsiderMcGeorge Anne
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 10, 2026
Filing dateAugust 11, 2026
Shares owned after1,250
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026.